Epithalon vs Urolithin A
A side-by-side research comparison of Epithalon and Urolithin A across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Epithalon | Urolithin A |
|---|---|---|
| Full name | Epithalon (Epitalon / Epithalone) | Urolithin A (Mitophagy Activator) |
| Category | Anti-Aging | Anti-Aging |
| Status | Research compound | Dietary compound (clinical studies) |
| Mechanism | Activates telomerase reverse transcriptase (hTERT) expression for telomere maintenance. Also normalizes circadian rhythm via melatonin regulation and modulates antioxidant enzymes. | Stimulates mitophagy - the selective recycling of damaged mitochondria - improving mitochondrial quality and energy efficiency in muscle and other tissues. |
| Molecular weight | 390.4 Da | 228.20 Da |
| Half-life | 3-4 hours | Several hours |
| Bioavailability | High (SubQ) | Oral; bypasses the need for the gut bacteria many people lack |
| Typical dose | 5-10 mg | 500-1000 mg per day |
| Frequency | Daily for 10-20 days | Once daily |
| Route | Subcutaneous injection | Oral |
Epithalon reported benefits
- Telomerase activation
- Telomere lengthening
- Melatonin normalization
- Improved sleep patterns
- Antioxidant enzyme upregulation
- Potential lifespan extension
Urolithin A reported benefits
- Improves mitochondrial function (mitophagy)
- Increased muscle endurance
- Cellular energy support
- Studied for healthy aging
Related comparisons
Research and educational reference only. Not medical advice.